Caliper's Q1 Revenues Jump 25 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Caliper Life Sciences today reported that its first-quarter revenues increased 25 percent as sales of its imaging and LabChip products returned strong double-digit gains.

The Hopkinton, Mass.-based firm brought in total revenues of $35.8 million for the three-month period ended March 31, compared to $28.7 million for the first quarter of 2010. Its revenues were driven by sales of its imaging and LabChip products, while its automation business declined.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.